MedPath

To determine the diagnostic accuracy of MRI in detecting lymph node metastases using USPIO (Ultra small super-paramagnetic iron oxide particles) in patients with gynecological malignancy

Conditions
Gynaecological malignancies
Registration Number
EUCTR2004-002053-31-GB
Lead Sponsor
Hammersmith Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

1. Adults patients with gynecological malignancy
2. Patients who have provided informed cosent
3. Effective contraception, menopause or surgical sterilisation must be confrimed
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Patients allergic to dextran or iron salts
2. Patients involved in other trials including a molecule under development
3. Female patients who are breast feeding
4. Contra-indication to MRI

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath